Puriblood Medical Co., Ltd. (6847.TWO)
TWD 101.5
(-1.93%)
TWD 101.5
(-1.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 26.64 Million | -30.83 Million | -43.68 Million | -9.62 Million | -15.53 Million |
| Net Income | -54.42 Million | 16.93 Million | -38.02 Million | -2.77 Million | -20.55 Million |
| Depreciation & Amortization | 8.09 Million | 7.76 Million | 6.42 Million | 5.16 Million | 4.07 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | 86 Thousand | 230 Thousand | - |
| Change in working capital | 68.39 Million | -45.76 Million | -16.16 Million | -13.27 Million | 642 Thousand |
| Other non-cash items | -598 Thousand | 743 Thousand | 2.83 Million | 1.04 Million | 302 Thousand |
| Investing Cash Flow | -3.24 Million | -25.63 Million | -24.35 Million | -15.82 Million | -5.4 Million |
| Investments in PPE | -6.34 Million | -11.47 Million | -5.09 Million | -10.08 Million | -4.17 Million |
| Acquisitions | 3 Million | -13.5 Million | - | -5.75 Million | - |
| Investment purchases | - | - | -20 Million | - | - |
| Sales/Maturities of investments | 3 Million | - | - | - | - |
| Other Investing Activities | 101 Thousand | -799 Thousand | 739 Thousand | -87 Thousand | -1.22 Million |
| Financing Cash Flow | -5.41 Million | 24.09 Million | 100.06 Million | 112.05 Million | 14.62 Million |
| Debt repayment | -3.72 Million | -27.54 Million | -2.4 Million | -6.97 Million | -2.87 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 108.3 Million | 120 Million | - |
| Other Financing Activities | -443 Thousand | -2.23 Million | -4.65 Million | 171 Thousand | 11.75 Million |
| Accounts receivables | 10.06 Million | -10.32 Million | 7.13 Million | -13.42 Million | -1.48 Million |
| Accounts payables | 11.26 Million | - | - | - | - |
| Inventory | 6.61 Million | -13.5 Million | -11.96 Million | -2.04 Million | -2.62 Million |
| Other working capital | 48.33 Million | -31.4 Million | -12.49 Million | 2.09 Million | 4.75 Million |
| Cash at beginning of period | 99.49 Million | 131.86 Million | 99.83 Million | 13.22 Million | 19.54 Million |
| Cash at end of period | 117.48 Million | 99.49 Million | 131.86 Million | 99.83 Million | 13.22 Million |
| Capital Expenditure | -6.34 Million | -11.47 Million | -5.09 Million | -10.08 Million | -4.17 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 17.98 Million | -32.37 Million | 32.03 Million | 86.6 Million | -6.31 Million |
| Free Cash Flow | 20.29 Million | -42.3 Million | -48.77 Million | -19.7 Million | -19.7 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.2 Million | -6.2 Million | -54.42 Million | -16.66 Million | -16.66 Million | -9.13 Million |
| Depreciation & Amortization | 2.11 Million | 2.11 Million | 8.09 Million | 2.02 Million | 2.02 Million | 1.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.39 Million | -2.39 Million | 68.39 Million | 28.51 Million | 28.51 Million | 3.98 Million |
| Other non-cash items | -2.44 Million | -2.44 Million | -598 Thousand | 1.65 Million | 1.65 Million | 960.5 Thousand |
| Investing Cash Flow | -172 Thousand | -172 Thousand | -3.24 Million | -2 Million | -2 Million | 378.5 Thousand |
| Investments in PPE | -572 Thousand | -572 Thousand | -6.34 Million | -1.6 Million | -1.6 Million | -1.51 Million |
| Acquisitions | - | - | 3 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 400 Thousand | 400 Thousand | 101 Thousand | -394.49 Thousand | -394.49 Thousand | 1.89 Million |
| Financing Cash Flow | -1.98 Million | -1.98 Million | -5.41 Million | -2.15 Million | -2.15 Million | -553.5 Thousand |
| Debt repayment | -3.32 Million | - | -3.72 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.98 Million | -1.98 Million | -443 Thousand | -2.15 Million | -2.15 Million | -553.5 Thousand |
| Accounts receivables | 2.77 Million | 2.77 Million | 10.06 Million | -1.91 Million | -1.91 Million | 6.95 Million |
| Accounts payables | -6.24 Million | - | - | - | - | - |
| Inventory | -3.67 Million | -3.67 Million | 6.61 Million | 6.02 Million | 6.02 Million | -2.71 Million |
| Other working capital | -1.49 Million | -1.49 Million | 48.33 Million | 24.41 Million | 24.41 Million | -251.5 Thousand |
| Cash at beginning of period | 117.48 Million | - | 99.49 Million | - | - | - |
| Cash at end of period | -11.08 Million | -11.08 Million | 117.48 Million | 11.37 Million | 11.37 Million | -2.38 Million |
| Capital Expenditure | -572 Thousand | -572 Thousand | -6.34 Million | -1.6 Million | -1.6 Million | -1.51 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -128.56 Million | -11.08 Million | 17.98 Million | 11.37 Million | 11.37 Million | -2.38 Million |
| Free Cash Flow | -9.5 Million | -9.5 Million | 20.29 Million | 13.92 Million | 13.92 Million | -3.72 Million |
ARAD
108230
COR
DRKTY
BRKHW
6579